Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;55(4):546-54.
doi: 10.1016/j.neuropharm.2008.06.057. Epub 2008 Jul 4.

Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP

Affiliations

Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP

Jason P Schroeder et al. Neuropharmacology. 2008 Sep.

Abstract

Relapse to alcohol use after periods of abstinence is a hallmark behavioral pathology of alcoholism and a major clinical problem. Emerging evidence indicates that metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate relapse to alcohol-seeking behavior but the molecular mechanisms of this potential therapeutic effect remain unexplored. The extracellular signal-regulated kinase (ERK1/2) pathway is downstream of mGluR5 and has been implicated in addiction. We sought to determine if cue-induced reinstatement of alcohol-seeking behavior, and its reduction by an mGluR5 antagonist, is associated with changes in ERK1/2 activation in reward-related limbic brain regions. Selectively-bred alcohol-preferring (P) rats were trained to lever press on a concurrent schedule of alcohol (15% v/v) vs. water reinforcement. Following 9 days of extinction, rats were given an additional extinction trial or injected with the mGluR5 antagonist MPEP (0, 1, 3, or 10mg/kg) and tested for cue-induced reinstatement. Brains were removed 90-min later from the rats in the extinction and MPEP (0 or 10mg/kg) conditions for analysis of p-ERK1/2, total ERK1/2, and p-ERK5 immunoreactivity (IR). Cue-induced reinstatement of alcohol-seeking behavior was associated with a three to five-fold increase in p-ERK1/2 IR in the basolateral amygdala and nucleus accumbens shell. MPEP administration blocked both the relapse-like behavior and increase in p-ERK1/2 IR. p-ERK1/2 IR in the central amygdala and NAcb core was dissociated with the relapse-like behavior and the pharmacological effect of mGluR5 blockade. No changes in total ERK or p-ERK5 were observed. These results suggest that exposure to cues previously associated with alcohol self-administration is sufficient to produce concomitant increases in relapse-like behavior and ERK1/2 activation in specific limbic brain regions. Pharmacological compounds, such as mGluR5 antagonists, that reduce cue-induced ERK1/2 activation may be useful for treatment of relapse in alcoholics that is triggered by exposure to environmental events.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Extinction of alcohol-reinforced lever pressing. Data are plotted as mean (± SEM) total responses per session on the ethanol and water levers on the last day of baseline (left) and through the 9 days of extinction training (right). Data represent an average of 5 treatment groups (N=31) shown in the lower panel. (B) Effect of the mGluR5 antagonist on cue-induced reinstatement of alcohol-seeking behavior. Data are shown as mean (± SEM) total responses on day 10 of the procedure. Bars show performance of a group that continued on extinction training (Ext) as compared to groups that received MPEP (0 – 10 mg/kg) prior to a cue-induced reinstatement test session. Data represent mean of n=6–7 rats from each drug dose / condition. * - significantly different from water on the same day; † - significantly different from Ext within the same reinforcement condition; ‡ - significantly different from MPEP (0 mg/kg) within the same reinforcement condition, p < 0.05, Tukey test.
Figure 2
Figure 2. p-ERK1/2 IR in nucleus accumbens shell
(A) Mean (± S.E.M.) p-ERK1/2 immunoreactivity (pixels/mm2) in the nucleus accumbens shell following extinction (Ext) or cue-induced reinstatement with MPEP (0 or 10 mg/kg) pretreatment. (B) Illustration of brain regions analyzed (adapted from Paxinos and Watson, 1998; nucleus accumbens core – AcbC; nucleus accumbens shell – AcbSh). (C) Representative photomicrographs of the cytological pattern of p-ERK1/2 IR in the nucleus accumbens shell following Extinction or cue-induced reinstatement with MPEP (0 or 10 mg/kg) pretreatment. Data represent means of multiple brain sections from n=6 rats per condition. * - indicates significantly different from Ext; † - significantly different from MPEP (0 mg/kg), p<0.05, Tukey test.
Figure 3
Figure 3. p-ERK1/2 IR in basolateral amygdala
(A) Mean (± S.E.M.) p-ERK1/2 IR (pixels/mm2) in the basolateral amygdala following extinction (Ext) or cue-induced reinstatement with MPEP (0 or 10 mg/kg) pretreatment. (B) Illustration of brain regions analyzed (adapted from Paxinos and Watson, 1998; basolateral amygdala - BLA; central nucleus of the amygdala – CeA. (C) Representative photomicrographs of the cytological pattern of p-ERK1/2 IR in the basolateral amygdala following Extinction or cue-induced reinstatement with MPEP (0 or 10 mg/kg) pretreatment. Data represent means of multiple brain sections from n=6 rats per condition. * - indicates significantly different from Ext; † - significantly different from MPEP (0 mg/kg), p<0.05, Tukey test.

References

    1. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem. 1996;271:16586–16590. - PubMed
    1. Anderson NG, Maller JL, Tonks NK, Sturgill TW. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 1990;343:651–653. - PubMed
    1. Anton RF, Kranzler HR, Meyer RE. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clin Neurosci. 1995;3:145–154. - PubMed
    1. Aroor AR, Shukla SD. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004;74:2339–2364. - PubMed
    1. Bachtell RK, Tsivkovskaia NO, Ryabinin AE. Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms. J Pharmacol Exp Ther. 2002;302:516–524. - PubMed

Publication types

MeSH terms

Substances